- FOLD has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $23.2 million.
- FOLD has traded 178,235 shares today.
- FOLD is down 3.6% today.
- FOLD was up 20.4% yesterday.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in FOLD with the Ticky from Trade-Ideas. See the FREE profile for FOLD NOW at Trade-Ideas More details on FOLD: Amicus Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines for various rare and orphan diseases. Currently there are 3 analysts that rate Amicus Therapeutics a buy, no analysts rate it a sell, and none rate it a hold. The average volume for Amicus Therapeutics has been 1.8 million shares per day over the past 30 days. Amicus has a market cap of $358.1 million and is part of the health care sector and drugs industry. The stock has a beta of 1.76 and a short float of 8.1% with 0.31 days to cover. Shares are up 94.5% year-to-date as of the close of trading on Tuesday. STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.